[Clinical considerations on betamethasone disodium phosphate with delayed action (Celestone A.R.)].
D001623:Betamethasone / Q000627:therapeutic use*; D003141:Communicable Diseases / Q000188:drug therapy*; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D003872:Dermatitis / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012213:Rheumatic Fever / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D001623:Betamethasone
Considerazioni cliniche sul betametasone fosfato disodico ad azione ritardata (Celestone A.R.)